You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atezolizumab

Showing 26 - 50 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Atezolizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 23, 2022

Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Birmingham, Alabama
  • +2 more
Nov 21, 2022

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Atezolizumab
  • +3 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Aug 30, 2022

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

Active, not recruiting
  • Breast Cancer
  • Atezolizumab
  • Stereotactic radiosurgery (SRS)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 15, 2022

Hepatocellular Carcinoma Trial in Tampa (Selinexor Pill, Bevacizumab, Atezolizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Selinexor Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Y-90 TARE
  • +2 more
  • Washington, District of Columbia
  • +5 more
Jan 18, 2023

Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

Active, not recruiting
  • Gastrointestinal Cancer
  • New York, New York
  • +1 more
Nov 29, 2022

Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

Recruiting
  • Colorectal Cancer
  • Omaha, Nebraska
    Exelixis Clinical Site #1
Jul 26, 2022

Rectal Tumors Trial in Belgium (Atezolizumab, 5-FU based radio-chemo)

Recruiting
  • Rectal Neoplasms
  • Atezolizumab
  • 5-FU based radio-chemotherapy
  • Charleroi, Hainaut, Belgium
  • +4 more
Dec 14, 2022

Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Cholangiocarcinoma
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Metastatic Colorectal Cancer Trial in Pisa (Bevacizumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Pisa, Italia, Italy
    Francesca Vannini
Jan 4, 2023

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Berlin, Germany
  • +5 more
Jan 2, 2023

Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Talimogene laherparepvec
  • Atezolizumab
  • Barcelona, Spain
  • +3 more
Sep 27, 2022

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Atezolizumab
  • +5 more
  • (no location specified)
Jan 18, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Atezolizumab
  • +2 more
  • San Francisco, California
  • +1 more
Oct 8, 2022

Breast Cancer Trial (Letrozole, Atezolizumab)

Withdrawn
  • Breast Cancer
  • (no location specified)
Jun 10, 2022

Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Atezolizumab
  • +4 more
  • London, United Kingdom
    Barts Health NHS Trust
Aug 10, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022